Heartfelt stories put eyes on PBAC

Posted 25 November 2024 PM

Heart-wrenching stories across mainstream media calling for the PBS listing of Johnson & Johnson's Rybrevant for Exon-20 lung cancer are creating mounting public pressure for a positive recommendation for the drug which was considered at PBAC's November meeting.

Channel Nine's A Current Affair and Mamamia have both spotlighted the story of  34-year-old Jemma Juckes' - diagnosed last year with stage four non-small cell lung cancer (NSCLC) with an EGFR Exon 20 mutation.

To see the whole article, please login